Overall Technical outlook

Price Summary

On 2026-02-02, TORNTPHARM's stock opened at 4018.5, reached a peak of 4018.5, dropped to 3903.9, and ended -0.78% down at 3987.2, with a volume of 293116 shares.
In the last 52 weeks, the stock's top price was 4092.2 and the bottom price was 2930.3.
The price projection is between 3530.0 and 4380.0, with an average expected price around 4024.2693, according to 26 analysts.

Technicals

Support and Resistance: The price of 3987.2 is supported at 3949.8 and faces resistance at 4092.2. This range suggests key levels for TORNTPHARM where the price may stabilize, with 3949.8 acting as a support and 4092.2 as a cap on gains.
TORNTPHARM supportResistance e2bace
Support/Resistance for TORNTPHARM


Aroon: The AROON is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
TORNTPHARM aroon e2bace
Aroon chart for Torrent Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is showing a neutral stance, not indicating a clear upward or downward trend for Torrent Pharmaceuticals Limited. This suggests a period of market balance, where neither side is showing dominance.
TORNTPHARM bbands e2bace
Bolinger Bands chart for Torrent Pharmaceuticals Limited


Parabolic SAR: The PSAR continues its bearish outlook, setting a key resistance level that could limit upward potential. This resistance suggests that the market may struggle to break higher, reflecting ongoing bearish pressure for TORNTPHARM.
TORNTPHARM psar e2bace
Parabolic Stop and Reverse chart for Torrent Pharmaceuticals Limited


Stochastic: The current state of the STOCHASTIC is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
TORNTPHARM stoch e2bace
Stochastic chart for Torrent Pharmaceuticals Limited


Tripple Moving Agerage: The 20, 50, and 100 moving averages are currently aligned in a bearish pattern, indicating a downtrend. However, the slopes of the 20 and 50 SMAs are showing signs of wavering, suggesting that the bearish momentum for TORNTPHARM may be fading. This could signal a potential shift towards bullish price action, as the market's downward trajectory begins to lose strength and prepares for a possible reversal.
TORNTPHARM trippleSMA e2bace
Tripple SMA chart for Torrent Pharmaceuticals Limited


A company's technical data, including stock price and trading volume, can provide valuable insights when considered alongside its fundamentals. These include financial performance, market share, and growth strategy, as well as broader industry dynamics. Examining these factors helps investors or analysts make more informed decisions, as the company's fundamentals offer context for understanding how and why certain technical patterns may emerge in the market.